Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,012Revenue (TTM) $M10,627Net Margin (%)-7.1Altman Z-Score0.3
Enterprise Value $M38,363EPS (TTM) $-2.1Operating Margin %9.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.3Pre-tax Margin (%)-6.5Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %19.7Quick Ratio1.1Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %87.2Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow3.5y-y EBITDA Growth Rate %12.7ROA % (ttm)-1.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-12.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M343ROIC % (ttm)-10.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2016-03-31 Reduce-17.01%$26.3 - $102.4
($74.84)
$ 20.40-73%Reduce -67.46%2,034,281
VRXRuane Cunniff 2016-03-31 Reduce-2.93%$26.3 - $102.4
($74.84)
$ 20.40-73%Reduce -14.32%30,308,449
VRXSteve Mandel 2016-03-31 Sold Out -2.53%$26.3 - $102.4
($74.84)
$ 20.40-73%Sold Out0
VRXBill Ackman 2016-03-31 Add1.48%$26.3 - $102.4
($74.84)
$ 20.40-73%Add 30.14%21,591,122
VRXDavid Tepper 2016-03-31 Buy 0.44%$26.3 - $102.4
($74.84)
$ 20.40-73%New holding945,000
VRXChris Davis 2016-03-31 Add0.4%$26.3 - $102.4
($74.84)
$ 20.40-73%Add 91.34%7,240,337
VRXLou Simpson 2016-03-31 Reduce-0.36%$26.3 - $102.4
($74.84)
$ 20.40-73%Reduce -3.97%2,591,399
VRXArnold Schneider 2016-03-31 Buy 0.34%$26.3 - $102.4
($74.84)
$ 20.40-73%New holding66,000
VRXFirst Eagle Investment 2016-03-31 Reduce-0.04%$26.3 - $102.4
($74.84)
$ 20.40-73%Reduce -8.83%1,495,332
VRXPrivate Capital 2016-03-31 Add0.02%$26.3 - $102.4
($74.84)
$ 20.40-73%Add 1.97%342,916
VRXJoel Greenblatt 2016-03-31 Buy $26.3 - $102.4
($74.84)
$ 20.40-73%New holding15,088
VRXJohn Paulson 2016-03-31 Add$26.3 - $102.4
($74.84)
$ 20.40-73%Add 0.14%13,284,800
VRXBill Ackman 2015-12-31 Reduce-3.69%$70.32 - $182.32
($111.15)
$ 20.40-82%Reduce -14.80%16,591,122
VRXWallace Weitz 2015-12-31 Sold Out -3.52%$70.32 - $182.32
($111.15)
$ 20.40-82%Sold Out0
VRXJohn Paulson 2015-12-31 Add2.74%$70.32 - $182.32
($111.15)
$ 20.40-82%Add 49.22%13,265,900
VRXGlenn Greenberg 2015-12-31 Add2.72%$70.32 - $182.32
($111.15)
$ 20.40-82%Add 12.09%6,252,331
VRXLou Simpson 2015-12-31 Add2.51%$70.32 - $182.32
($111.15)
$ 20.40-82%Add 38.18%2,698,614
VRXLeon Cooperman 2015-12-31 Sold Out -1.75%$70.32 - $182.32
($111.15)
$ 20.40-82%Sold Out0
VRXSteve Mandel 2015-12-31 Reduce-1.23%$70.32 - $182.32
($111.15)
$ 20.40-82%Reduce -21.88%5,829,079
VRXChris Davis 2015-12-31 Add0.97%$70.32 - $182.32
($111.15)
$ 20.40-82%Add 150.74%3,784,012
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-16.39view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-16.67view
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-74.01view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-88.77view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-90.73view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-90.93view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-91.98view
Rosiello Robert L.Executive Vice President 2015-06-12Buy12,900$232.51-91.23view
UBBEN JEFFREY W 2015-06-10Sell4,200,000$220.24-90.74view
Farmer Ronald HaroldDirector 2015-06-09Buy1,000$260.63-92.17view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
Steve Mandel Exits Position in Williams Companies in 1st Quarter Jun 24 2016 
Valeant CEO Joseph Papa Buys $5 Million of Company's Shares Jun 15 2016 
Ackman Cuts Stake in Air Products by Nearly 13 Million Shares Jun 13 2016 
Sequoia Fund Nearly Halves Stake in Valeant Jun 07 2016 
Bill Ackman Asked Charlie Munger to Be Nicer About Valeant in Released Email Jun 03 2016 
Pershing Square's, and Ackman’s, Less Talked About Positions May 27 2016 
Wally Weitz Sells Stake in Endo International, a Stock Down 75% May 26 2016 
David Tepper Exits Apple, Buys Facebook and Energy May 17 2016 
Francis Chou Takes Stake in Valeant, Coal Company May 13 2016 
Bill Ackman Comments on Valeant May 11 2016 

More From Other Websites
[$$] Pershing Square Lays Off Eight Lower-Level Employees Jul 01 2016
Valeant (VRX) Stock Gains Amid Baush + Lomb Optimism Jul 01 2016
AstraZeneca Transfers Valeant's European Rights To Troubled Drug Jul 01 2016
Valeant Climbs As Stifel Sees Enthusiasm For New Bausch + Lomb Products Jul 01 2016
Ackman vs. Madoff: Who's Hurting Hedge Funds More? Jul 01 2016
More Bad News for Ackman? (PSHZF) Jul 01 2016
No Burning Desire for Valeant’s Female Arousal Drug: Chart Jul 01 2016
3:22 am Valeant Pharma receives new licensing arrangement for Brodalumab in Europe; receives upfront... Jul 01 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe Jul 01 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe Jul 01 2016
Valeant Pharmaceuticals Announces New Licensing Arrangement For Brodalumab In Europe Jul 01 2016
How Will Pershing Fare in June? Look at Valeant Jun 29 2016
Valeant Is Cash-Poor, and Even Bausch & Lomb Division May Not Save It Jun 29 2016
Valeant Needs Cash and 'Crown Jewel' Bausch & Lomb May Be Losing Value Jun 29 2016
Valeant May Have 'Paid Too Much' for Its So-Called 'Crown Jewel' Assets Jun 29 2016
Valeant Pharmaceuticals: 'Very Big Clouds' Jun 29 2016
Valeant Pharmaceuticals (VRX) Stock Slumps, BMO Initiates Coverage Jun 29 2016
Forget Valeant, Invest in These Attractive Drug Stocks Instead Jun 28 2016
Endo International: Finally…Some Good News! Jun 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)